Cargando…

Polymorphisms of the Proinflammatory Cytokine Genes Modulate the Response to NSAIDs but Not to Triptans in Migraine Attacks

Migraine is a common neurovascular disorder characterized by recurrent episodes of headache and associated neurological symptoms. At present, a significant portion of patients do not obtain a satisfactory response to acute pain-relieving therapies, including NSAIDs and triptans. In this context, pha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rubino, Elisa, Marcinnò, Andrea, Grassini, Alberto, Piella, Elisa Maria, Ferrandes, Fabio, Roveta, Fausto, Boschi, Silvia, Cermelli, Aurora, Gallone, Salvatore, Savi, Lidia, Rainero, Innocenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820603/ https://www.ncbi.nlm.nih.gov/pubmed/36614097 http://dx.doi.org/10.3390/ijms24010657

Ejemplares similares

Aβ42 as a Biomarker of Alzheimer’s Disease: Is Saliva a Viable Alternative to Cerebrospinal Fluid?
por: Boschi, Silvia, et al.
Publicado: (2022)

Impact of COVID-19 on chronic migraine treated with erenumab: a case report
por: Grassini, Alberto, et al.
Publicado: (2021)

A Novel PSEN1 Variant Leading to Posterior Cortical Atrophy: A Case Report
por: Roveta, Fausto, et al.
Publicado: (2023)

Investigating p62 Concentrations in Cerebrospinal Fluid of Patients with Dementia: A Potential Autophagy Biomarker In Vivo?
por: Rubino, Elisa, et al.
Publicado: (2022)

Decreased resistin plasmatic concentrations in patients with Alzheimer's disease: A case-control study
por: Marcinnò, Andrea, et al.
Publicado: (2022)

Analysis of the DNA methylation pattern of the promoter region of calcitonin gene-related peptide 1 gene in patients with episodic migraine: An exploratory case-control study
por: Rubino, Elisa, et al.
Publicado: (2022)

Effects of COVID-19 on a migrainous patient treated with erenumab: A case report
por: Grassini, Alberto, et al.
Publicado: (2021)

Increased orexin A concentrations in cerebrospinal fluid of patients with behavioural variant frontotemporal dementia
por: Roveta, Fausto, et al.
Publicado: (2021)

Network meta-analysis of migraine disorder treatment by NSAIDs and triptans
por: Xu, Haiyang, et al.
Publicado: (2016)

Genetic variants in the NOTCH4 gene influence the clinical features of migraine
por: Rubino, Elisa, et al.
Publicado: (2013)

Evidence for an association between migraine and the hypocretin receptor 1 gene
por: Rainero, Innocenzo, et al.
Publicado: (2011)

O057. Altered plasma adipokines concentrations in chronic migraine
por: Rubino, Elisa, et al.
Publicado: (2015)

O056. Migraine as presenting symptom of SLC20A2gene mutations
por: Rubino, Elisa, et al.
Publicado: (2015)

Efficacy of frovatriptan as compared to other triptans in migraine with aura
por: Evers, Stefan, et al.
Publicado: (2015)

P055. Prevalence of migraine in subclinical hypothyroidism: a case-control study
por: Rainero, Innocenzo, et al.
Publicado: (2015)

The Carers’ Needs Assessment for Dementia (CNA-D): a validation study in the Italian population
por: Zucca, Milena, et al.
Publicado: (2021)

Anxiety and depression in Alzheimer’s disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline
por: Botto, Rossana, et al.
Publicado: (2022)

Association between the G1246A polymorphism of the hypocretin receptor 2 gene and cluster headache: a meta-analysis
por: Rainero, Innocenzo, et al.
Publicado: (2007)

Investigating the genetic role of aquaporin4 gene in migraine
por: Rubino, Elisa, et al.
Publicado: (2009)

Multi-omic analyses of triptan-treated migraine attacks gives insight into molecular mechanisms
por: Kogelman, Lisette J. A., et al.
Publicado: (2023)

Predicting the response to a triptan in migraine using deep attack phenotyping: A feasibility study
por: Viana, Michele, et al.
Publicado: (2020)

European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
por: Sacco, Simona, et al.
Publicado: (2022)

Stroke, Migraine and Triptans: From Bedside to Bench
por: Raschi, Emanuel, et al.
Publicado: (2016)

Association between migraine and HLA–DRB1 gene polymorphisms
por: Rainero, I., et al.
Publicado: (2005)

Headaches related to triptans therapy in patients of migrainous vertigo
por: Prakash, Sanjay, et al.
Publicado: (2008)

Cluster headache attacks and multiple sclerosis
por: Gentile, Salvatore, et al.
Publicado: (2007)

Migraine during COVID-19: Data from Second Wave Pandemic in an Italian Cohort
por: Gentile, Eleonora, et al.
Publicado: (2021)

Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine
por: Gentile, Giovanna, et al.
Publicado: (2010)

Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine
por: Gentile, Giovanna, et al.
Publicado: (2010)

Investigating the Effects of COVID-19 Quarantine in Migraine: An Observational Cross-Sectional Study From the Italian National Headache Registry (RICe)
por: Delussi, Marianna, et al.
Publicado: (2020)

Up to date on the use of triptans for child and adolescent migraine: state of the art
por: Calderoni, Dario, et al.
Publicado: (2001)

Triptans in prevention of menstrual migraine: a systematic review with meta-analysis
por: Hu, Yong, et al.
Publicado: (2013)

Triptans Use for Migraine Headache among Nonelderly Adults with Cardiovascular Risk
por: Alwhaibi, Monira, et al.
Publicado: (2016)

Acute treatment patterns in patients with migraine newly initiating a triptan
por: Lipton, Richard B, et al.
Publicado: (2020)

Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans
por: Knievel, Kerry, et al.
Publicado: (2019)

Lasmiditan for Patients with Migraine and Contraindications to Triptans: A Post Hoc Analysis
por: Krege, John H., et al.
Publicado: (2022)

Costs and Utilization of Triptan Users Who Receive Drug Prophylaxis for Migraine Versus Triptan Users Who Do Not Receive Drug Prophylaxis
por: Etemad, Lida R., et al.
Publicado: (2005)

Pathophysiological Bases of Comorbidity in Migraine
por: Altamura, Claudia, et al.
Publicado: (2021)

Neuropsychological Correlates of Pre-Frailty in Neurocognitive Disorders: A Possible Role for Metacognitive Dysfunction and Mood Changes
por: Amanzio, Martina, et al.
Publicado: (2017)

Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan
por: Diener, Hans-Christoph, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_seeujolc5hcmrmltt7j102013i